Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders

Комплексное изучение генетического вклада дофаминергических и серотонинергических путей в развитие психических расстройств
Andreas Reif, Bàrbara Torrico, Bru Cormand, Noèlia Fernàndez‐Castillo, Judit Cabana‐Domínguez
2022-01-10

dopaminergic pathwaysgene-set analysisgenome-wide association studiespsychiatric disordersserotonergic pathways
Psychiatric disorders are highly prevalent and display considerable clinical and genetic overlap. Dopaminergic and serotonergic neurotransmission have been shown to play an important role in many psychiatric disorders. Here we aim to assess the genetic contribution of these systems to eight psychiatric disorders (attention-deficit hyperactivity disorder (ADHD), anorexia nervosa (ANO), autism spectrum disorder (ASD), bipolar disorder (BIP), major depression (MD), obsessive-compulsive disorder (OCD), schizophrenia (SCZ) and Tourette's syndrome (TS)) using publicly available GWAS analyses performed by the Psychiatric Genomics Consortium that include more than 160,000 cases and 275,000 controls. To do so, we elaborated four different gene sets: two 'wide' selections for dopamine (DA) and for serotonin (SERT) using the Gene Ontology and KEGG pathways tools, and two'core' selections for the same systems, manually curated. At the gene level, we found 67 genes from the DA and/or SERT gene sets significantly associated with one of the studied disorders, and 12 of them were associated with two different disorders. Gene-set analysis revealed significant associations for ADHD and ASD with the wide DA gene set, for BIP with the wide SERT gene set, and for MD with the core SERT set. Interestingly, interrogation of a cross-disorder GWAS meta-analysis of the eight psychiatric conditions displayed association with the wide DA gene set. To our knowledge, this is the first systematic examination of genes encoding proteins essential to the function of these two neurotransmitter systems in these disorders. Our results support a pleiotropic contribution of the dopaminergic and serotonergic systems in several psychiatric conditions.
1
Cross-disorder analysis associated the wide dopamine gene set with shared genetic risk across the eight disorders, supporting pleiotropic neurotransmitter-system effects.
2
Gene-set analyses linked the wide dopamine set to ADHD and ASD, the wide serotonin set to bipolar disorder, and the core serotonin set to major depression.
3
Researchers constructed wide and manually curated core gene sets representing dopamine and serotonin pathways.
4
Sixty-seven dopamine and/or serotonin genes were significantly associated with at least one disorder, including 12 genes associated with two disorders.
5
The study assessed dopaminergic and serotonergic genetic contributions across eight psychiatric disorders using GWAS data comprising over 160,000 cases and 275,000 controls.

Dopaminergic and serotonergic neurotransmitter systems in eight psychiatric disorders (ADHD, anorexia nervosa, ASD, bipolar disorder, major depression, OCD, schizophrenia, and Tourette's syndrome)

The genetic contribution and pleiotropic associations of dopaminergic and serotonergic pathway genes across the eight psychiatric disorders

Publication Details
Publication Date
2022-01-10
Journal
Publisher
ISSN
Cited by
78
Access Type
Author Information
Authors
Andreas Reif
Bàrbara Torrico
Bru Cormand
Noèlia Fernàndez‐Castillo
Judit Cabana‐Domínguez
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%